Developing therapies to target multiple immune pathways
28 Oct 2024
Formats & Scaffolds
- Combination vs. Bi-Specific Approaches: combining multiple mAbs to design multi-functional or bi-specific antibodies that engage multiple targets simultaneously.
- Developing therapies for multiple pathways requires precise control over dosing, often using combination dosing regimens.
- Higher potential for adverse effects.
Industry Experts
